After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...
LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
MUNICH — A novel implanted continuous glucose sensor (Eversense, Senseonics) is safe and accurately reflected blood glucose levels for an average of about 6 months, study results show. Data from the ...
This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback